These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2905276)

  • 1. [Mechanisms of the thrombocytic effects of beta-adrenoblockaders].
    Tumasian KS; Akopov SE; Gabrielian ES
    Farmakol Toksikol; 1988; 51(5):49-53. PubMed ID: 2905276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experimental research on the action of isoptin and alkylenediamine derivatives on the aggregation capacity and the membrane-bound calcium level of thrombocytes].
    Mironiuk EP; Manevich EM; Piotrovskiĭ LB; Dumpis MA
    Farmakol Toksikol; 1987; 50(2):42-6. PubMed ID: 3582633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of alpha- and beta-adrenergic antagonist on epinephrine-induced aggregation and intracellular free calcium concentration in human platelets.
    Kimura Y; Okuda H
    Biochem Biophys Res Commun; 1994 Jul; 202(2):1069-75. PubMed ID: 7914077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of alpha and beta receptor blocking agents with platelet release and availability reaction induced by ADP, adrenaline and collagen.
    Kubisz P; Caen J
    Pathol Biol (Paris); 1972 Dec; ():Suppl:34-40. PubMed ID: 4145190
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of platelet aggregation by ethanol in vitro shows specificity for aggregating agent used and is influenced by platelet lipid composition.
    Fenn CG; Littleton JM
    Thromb Haemost; 1982 Aug; 48(1):49-53. PubMed ID: 6813995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ca+2 mobilization and fibrinogen binding of platelets refractory to adenosine diphosphate stimulation.
    Peerschke EI
    J Lab Clin Med; 1985 Aug; 106(2):111-22. PubMed ID: 2991399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epinephrine-induced aggregation of rabbit platelets refractory to ADP.
    Lalau Keraly C; Kinlough-Rathbone RL; Mustard JF
    Thromb Haemost; 1985 Jun; 53(3):366-71. PubMed ID: 2996167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of raubasine and pipratecol on platelet aggregation and on the platelet release reaction].
    Cattaneo M; D'Angelo A; Mannucci PM; Pareti F; Vanasia S; Viganò
    Clin Ter; 1980 Feb; 92(4):359-68. PubMed ID: 6108818
    [No Abstract]   [Full Text] [Related]  

  • 9. [Platelet aggregation induced by adenosine diphosphate, collagen and adrenaline in human platelet subpopulations].
    Nubile G; Di Gregorio M; Ridolfi D; D'Alonzo L; Izzi L
    Quad Sclavo Diagn; 1987 Sep; 23(3):331-40. PubMed ID: 3140287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Platelet membrane aggregation by platelet aggregation provoking substances].
    Watanabe K; Ando Y; Ikeda Y; Deguchi N
    Rinsho Byori; 1979; Suppl 40():257-67. PubMed ID: 551228
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of sympathomimetic amines with collagen, calcium ionophor and adenosine diphosphate in their effects on thromboxane formation of human platelet rich plasma.
    Ditter H; Matthias FR; Lasch HG
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):761-8. PubMed ID: 6083951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation of prostaglandins during the aggregation of human blood platelets.
    Smith JB; Ingerman C; Kocsis JJ; Silver MJ
    J Clin Invest; 1973 Apr; 52(4):965-9. PubMed ID: 4693658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propofol does not affect platelet aggregation.
    Türkan H; Süer AH; Beyan C; Yalçin A
    Eur J Anaesthesiol; 1996 Jul; 13(4):408-9. PubMed ID: 8842666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggregation and release reaction in normal and abnormal platelets.
    Cronberg S
    Acta Univ Carol Med Monogr; 1972; 53():75-7. PubMed ID: 4670757
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of adrenergic blockers on platelet aggregation.
    Orts A; Martí JL; Marco J; Baltar I; Castejón J
    Rev Esp Fisiol; 1979 Sep; 35(3):269-72. PubMed ID: 41294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the non-selective beta-adrenoceptor blocking agent, carteolol, on platelet function, blood coagulation and viscosity.
    Small M; Douglas JT; Aherne GW; Orr M; Lowe GD; Forbes CD; Prentice CR
    Thromb Res; 1982 Feb; 25(4):351-60. PubMed ID: 6122288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subtype-selective antagonists of lysophosphatidic Acid receptors inhibit platelet activation triggered by the lipid core of atherosclerotic plaques.
    Rother E; Brandl R; Baker DL; Goyal P; Gebhard H; Tigyi G; Siess W
    Circulation; 2003 Aug; 108(6):741-7. PubMed ID: 12885756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desensitization of the platelet aggregation response to ADP: differential down-regulation of the P2Y1 and P2cyc receptors.
    Baurand A; Eckly A; Bari N; Léon C; Hechler B; Cazenave JP; Gachet C
    Thromb Haemost; 2000 Sep; 84(3):484-91. PubMed ID: 11019976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ultrastructural study of the action of a blood platelet anti-aggregant. Application to nicergoline].
    Le Menn R; Migne J; Prost-Dvojakovic RJ
    Therapie; 1977; 32(2):205-14. PubMed ID: 898128
    [No Abstract]   [Full Text] [Related]  

  • 20. [Potentiating effect of some fatty acids on platelet aggregation induced with ADP, collagen and 1-epinephrine].
    Musso R; Russo M; Raimondo V
    Boll Soc Ital Biol Sper; 1980 Mar; 56(6):569-75. PubMed ID: 7378191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.